Track the Moberg Pharma AB (publ) share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Moberg Pharma AB (publ) has recorded 18 public disclosures. Market capitalisation: €534.1m. The latest transaction was filed on 21 August 2026 (Sale). Among the most active insiders: Richard Ding. All data is free.
18
Insider Decl.
n/a
Thresholds
€108,690
15 ops.
Buy Volume
€775,781
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Moberg Pharma AB (publ) Strong Buy (bullish), based on 1 analysts. Average price target: SEK 16.00.
41Σ signal
Buys €108,690€775,781 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,490 shares@ SEK 6.4732.4% of flowBTU (betald tecknad unit)ISINISIN SE0015243761FI:A001P100-2
18 of 18 declarations
About Moberg Pharma AB (publ)
Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on developing treatments for skin diseases. It is listed on the Stockholm Stock Exchange (XSTO).